Fact check - The narrative mixes a number of scientific terms related to vaccines and then draws a false conclusion.
The company said it expects Qdenga to become available in India in the first half of 2027. Read more at straitstimes.com.
Serum Institute of India has partnered with Gates Medical Research Institute to manufacture M72/AS01E, a tuberculosis vaccine ...
India approves QDENGA, its first dengue vaccine, offering protection against all four dengue virus strains for people aged 4 ...
Google is expanding access to select AI tools for governments and researchers as scrutiny of biological risks associated with ...
Experimental KRAS Vaccine Generates Immune Response Against Pancreatic Cancer in People at High Risk
Researchers at the Johns Hopkins Kimmel Cancer Center and its Skip Viragh Center for Pancreatic Cancer report that an ...
Infectious bovine keratoconjunctivitis may be more complex than a single bacterial infection, opening new avenues for ...
His malaria vaccination appointment at a clinic in central Cameroon was too important to miss. For decades, millions of ...
Cecilia Ramirez spends her summer crisscrossing the Oklahoma City area. She drives a van decorated with smiling cartoon kids ...
India has approved its first dengue vaccine, QDENGA, for people aged 4 to 60 years. Know who can receive it, how the two-dose ...
On July 16, the launch ceremony of the event themed A Century of Legacy, A Future of Shared Prosperity – Commemorative ...
Takeda Biopharmaceuticals India has received market authorization for its dengue vaccine QDENGA. This vaccine is now approved for individuals aged four to sixty years old. QDENGA offers protection ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results